Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3535429rdf:typepubmed:Citationlld:pubmed
pubmed-article:3535429lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:3535429lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:3535429lifeskim:mentionsumls-concept:C0043436lld:lifeskim
pubmed-article:3535429pubmed:issue1lld:pubmed
pubmed-article:3535429pubmed:dateCreated1986-12-17lld:pubmed
pubmed-article:3535429pubmed:abstractTextThe contraceptive efficacy and clinical performance of Nova-T and TCu200Ag were studied in a randomized comparative study with 819 interval acceptors. The 1- and 2-year gross termination rates were evaluated by means of the life-table method. The 12-month pregnancy rates were 1.0 per 100 women with Nova-T and 3.0 per 100 women with TCu200Ag. The preliminary 2-year rates were 1.7 and 5.5 per 100 respectively (p = 0.037). Rates of expulsion, medical and personal removals were not significantly different for the two devices. Continuation rates for the first year were 89.4 and 90.5 per 100 respectively.lld:pubmed
pubmed-article:3535429pubmed:languageenglld:pubmed
pubmed-article:3535429pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3535429pubmed:citationSubsetIMlld:pubmed
pubmed-article:3535429pubmed:statusMEDLINElld:pubmed
pubmed-article:3535429pubmed:monthMarlld:pubmed
pubmed-article:3535429pubmed:issn0267-4874lld:pubmed
pubmed-article:3535429pubmed:authorpubmed-author:AllonenHHlld:pubmed
pubmed-article:3535429pubmed:authorpubmed-author:KozubGGlld:pubmed
pubmed-article:3535429pubmed:authorpubmed-author:Andols?kLLlld:pubmed
pubmed-article:3535429pubmed:issnTypePrintlld:pubmed
pubmed-article:3535429pubmed:volume2lld:pubmed
pubmed-article:3535429pubmed:ownerNLMlld:pubmed
pubmed-article:3535429pubmed:authorsCompleteYlld:pubmed
pubmed-article:3535429pubmed:pagination31-6lld:pubmed
pubmed-article:3535429pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:meshHeadingpubmed-meshheading:3535429-...lld:pubmed
pubmed-article:3535429pubmed:year1986lld:pubmed
pubmed-article:3535429pubmed:articleTitleA randomized comparative trial of Nova-T and TCu200Ag in Yugoslavia.lld:pubmed
pubmed-article:3535429pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3535429pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3535429pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3535429pubmed:publicationTypeRandomized Controlled Triallld:pubmed